Compare Novartis AG (NVS) vs Tempus AI (TEM) Price & Performance

Novartis AGTrade

Tempus AITrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Tempus AI — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Tempus AI trades at $49.01 (market cap $8.69B). The key difference: Novartis AG is far larger — about 33.4× Tempus AI's market cap, and Novartis AG pays a 3.17% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

	NVS	TEM
Market Cap	$290.25B	$8.69B
Sector	Health	Broad Market / Factor
52-Week High	$168.62	$103.25
52-Week Low	$113.50	$42.37
Enterprise Value	$330.27B	$9.37B
Dividend Yield	3.17%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 5 days agoBullish View details →

TEM

Needham downgrades Personalis to Hold after $1.5B Tempus AI acquisition deal announcedAlex Lavoie · 1 day agoBearish Law firm probes fairness of Tempus' $16.25/share acquisition offer for Personalis amid conflict concernsGlobeNewsWire · 1 day agoBearish Tempus AI to acquire cancer-monitoring firm Personalis for $1.5B in stock dealProactive Investors · 1 day agoBearish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.